Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
ALC1 deficiency increases olaparib-induced PARP1 trapping. (A) PARP1 at... | Download Scientific Diagram
Systematic inhibitor selectivity between PARP1 and PARP2 enzymes: Molecular implications for ovarian cancer personalized therapy - Zuo - 2021 - Journal of Molecular Recognition - Wiley Online Library
Inhibitors of PARP: Number crunching and structure gazing | PNAS
Frontiers | Poly(ADP-Ribose)Polymerase (PARP) Inhibitors and Radiation Therapy | Pharmacology
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/7-Figure4-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
Histone Parylation factor 1 contributes to the inhibition of PARP1 by cancer drugs | Nature Communications
Avoid the trap: Targeting PARP1 beyond human malignancy - ScienceDirect
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/5-Figure2-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
Ingo Hartung on Twitter: "First disclosure of #PARP1 selective inhibitor & trapper #AZD5305 at #AACR21: A 2nd generation PARP inhibitor for BRCA-mutated tumors with the potential for reduced haemato-toxicity (based on preclinical
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
IJMS | Free Full-Text | Differences in PARP Inhibitors for the Treatment of Ovarian Cancer: Mechanisms of Action, Pharmacology, Safety, and Efficacy | HTML
Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. - Abstract - Europe PMC
Advances and perspectives of PARP inhibitors | Experimental Hematology & Oncology | Full Text
Studying PAR-Dependent Chromatin Remodeling to Tackle PARPi Resistance: Trends in Molecular Medicine
PARP inhibitors in ovarian cancer - Cancer Treatment Reviews
Dissecting the molecular determinants of clinical PARP1 inhibitor selectivity for tankyrase1 - Journal of Biological Chemistry
PARP1 inhibitors trigger innate immunity via PARP1 trapping-induced DNA damage response | eLife
The Oncogenic Helicase ALC1 Regulates PARP Inhibitor Potency by Trapping PARP2 at DNA Breaks - ScienceDirect
Clinical PARP inhibitors (PARPis) and determinants of response and... | Download Scientific Diagram
Clinical PARP inhibitors (PARPis) and determinants of response and... | Download Scientific Diagram
PDF) 284 Differential Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
![PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e573d959ed1d8f231c3d4154ee1cac839c065548/8-Figure5-1.png "PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar")
PDF] Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors. | Semantic Scholar
